Concepedia
Statistics
Publications
68
Citations
5.2K
H-Index
33
Active since
2001
Affiliations
University of Chicago(Current)
Memorial Sloan Kettering Cancer Center
Cornell University
University of Tübingen
Pfizer (United States)
Russell Z. Szmulewitz is an author at University of Chicago specializing in medicine, oncology, and urology.
Top concepts
MedicineOncologyUrologyRadiation OncologyCancer TherapyPharmacotherapyPharmacologyClinical TrialsMolecular OncologyTumor Biology
Publications per year
2001–2024
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.1K citations · Full text
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Andrew J. Armstrong, Susan Halabi, Jun Luo et al. · Journal of Clinical Oncology · 2019 · 354 citations · Full text
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Andrew J. Armstrong, Arun Azad, Taro Iguchi et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
Masis Isikbay, Kristen Otto, Steven Kregel et al. · Hormones and Cancer · 2014 · 274 citations · Full text
Urology, Medicine, Androgen-targeted Therapy +6
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C. Danila et al. · Clinical Cancer Research · 2018 · 268 citations · Full text
Rows per page
1–5 of 68